drugset / Trial / NCT07548840
A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
NaSingle-groupOpen-labelTreatment
Summary
An open-label, single-arm clinical study of TS-172 in hyperphosphatemia patients on hemodialysis
Timeline
- Start
- 2026-05-08
- Primary completion
- 2026-11-30
- Completion
- 2026-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TS-172 | Unknown | 20 mg | Oral |
| Subject | TS-172 | Unknown | 60 mg | Oral |